Sign In
|
Register
|
About Los Altos
|
Contact Us
Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast
|
Traffic
Los Altos News
Local News
Bay Area News
Business
Technology
Real Estate
Sports
High School Sports
Los Altos Gas Prices
Ski And Snow Reports
Financial Markets
Bagels
Bakery
Barbecue
Coffee Houses
Continental
Deli
Fast Food
French
Ice Cream / Frozen Yogurt
Italian
Mexican
Pizza
Steaks, Chops
Sushi
Vietnamese
Wine
Museums
Family Fun
Arts & Culture
Parks
Annual Events
Accommodations
Hotel and Motel Management
Hotels & Resorts
Apartments
Art & Culture
Galleries & Dealers
Museums
Associations, Foundations and Organizations
Business & Professional Clubs
Civic, Social and Fraternal
Non-Profits
Professional & Trade Associations
Attractions & Entertainment
Amusement & Water Parks
Bowling, Billiards & Video Games
General Attractions
Golfing
Horseback Riding
Movie Theatres
Theatre
Automotive
Auto Rental
Dealers - New
Dealers - Used
Mobile Home Dealers
Motorcycles
Parts & Supplies
Radio & Alarm Systems
Repair & Service
Tires
Towing
Beauty & Fitness
Barbers
Beauty Salons
Cosmetics
Dance Clubs & Studios
Health Clubs & Gyms
Manicures
Nutrition
Skin Treatment
Yoga
Business & Professional Services
Appraisers
Building Maintenance & Janitorial
Business & Labor Organizations
Computer & Audio Visual Services
Consultants
Courier, Delivery & Messenger Service
Credit Check & Collection Agencies
Data Processing Service
Employment Services, Placement & Agencies
Engineer and Architect Services
Equipment & Supplies, Commercial & Industrial
Graphic Design & Art
Human Resource Services
Internet Services
Marketing & Advertising Services
Media Services
Notary Services
Photography
Printing & Publishing
Public Relations & Publicity
Security & Investigative Services
Shipping, Packaging & Postal Services
Signs & Banners
Staffing & Support Services
Translators & Interpreters
Contractors
Architects
Building Contractors & Consultants
Drywall, Plastering & Insulation
Electric
General Contractors
Heating, Cooling & AC
Landscaping
Painting & Wallcovering
Plumbing
Special Trade Contractors
Domestic Services
Child Care Services
Housecleaning
Pet Sitting and Day Care
Education
Colleges & Universities
Cont. Education
Elementary Schools
High Schools
Libraries
Preschools & Childcare
Private & Parochial
Public
Tutoring
Employment
Employment Agencies
Find or Post a Job
Temporary Help & Employment Contractors
Financial Services
Accountants & Tax
Banks & Credit Unions
Bookkeeping
Financial Brokers and Dealers
Financial Consultants
Financial Planning and Services
Investments
Loans
Mortgage Lenders
Golf
Government
Post Offices
State Government
Hair Salons
Health and Medicine
Alternative Medicine / Acupuncture
Chiropractors
Counseling
Dentistry
Dermatologists
Drug Stores & Pharmacies
Eye Care
Health Care Professionals
Home Health Care
Hospitals & Clinics
Medical Doctors
Medical Equipment & Supplies
Nutrition
Physical Therapist
Physicians & Surgeons
Social Services
Specialists - Health Care Professionals
Home & Garden
Appliances
Bed & Bath
Building Materials & Hardware
Cleaning Supplies & Services
Contractors
Domestic Services
Doors, Windows & Drapery
Floor Coverings
Furniture
Handyman
Home Improvement Centers
Interior Design & Decorating
Kitchen
Lamps & Lighting
Lawn & Garden
Locksmiths
Lumber
Nurseries & Garden Centers
Painting & Wallcoverings
Pest Control
Plumbing
Pools, Spas & Saunas
Safety & Security
Sewage & Septic Systems
Sprinklers
Insurance
Agents & Brokers
Health
Laser Hair Removal
Legal
Attorneys
Legal Services
Manufacturing & Industrial
Agriculture
Audio & Visual
Building Materials
Computers, Electronics & Telecommunications
Electronic Equipment
Food & Beverage
Industrial Supplies & Services
Machine Shops
Textiles & Apparel
Media
Radio Stations
Television Stations
Meeting & Event Planning
Event Facilities
Exhibit Designers
Meeting Planners
Party Rentals & Entertainment
Miscellaneous
Nightlife
Live Music
Personal Service
Child Care
Dry Cleaning and Laundry
Shoe Repair
Tailors and Alterations
Pets
Pet Grooming
Pet Supplies & Food - Retail
Veterinary Hospitals
Plastic Surgery
Aesthetic Surgeon
Plastic Surgeon
Real Estate
Appraisers
Assisted Living & Elder Care Service
Commercial
Developers
Property Management
Real Estate Agents and Brokers
Residential
Schools
Title Companies
Religion
Relocation
Storage
Restaurants
Bagels
Bakery
Barbecue
Coffee Houses
Continental
Deli
Fast Food
French
Ice Cream / Frozen Yogurt
Italian
Mexican
Pizza
Steaks, Chops
Sushi
Vietnamese
Wine
Shopping
Accessories
Antiques
Books
Cellular & Wireless
Children's and Infants Clothing
Clothing
Computer and Computer Software
Department Stores
Electronics
Flowers
Furniture
Gas Stations
Gifts & Specialty Shops
Grocery Stores
Health Food Stores
Home Improvement
Jewelry
Men's Clothing Stores
Pharmacies
Resale Shops
Shoe Stores
Shopping Centers & Malls
Smoke Shops
Sporting Goods
Thrift Stores
Toy Stores
Videos
Women's Clothing Stores
Spas
Day Spas
Resort Spas
Sports & Recreation
Arenas and Venues
Associations & Clubs
Equestrian
Golf Equipment & Supplies
Instruction
Martial Arts
Recreation Facilities
Skateboarding
Technology
Communications
Computer Services & Consultants
Internet Advertising & Services
Semiconductor
Software
Travel & Transportation
Airlines & Airports
Auto Rentals
Bus Lines & Charters
Taxi, Limousine & Shuttle
Tours & Excursions
Travel Agencies
Weddings
Cakes & Caterers
Your Business Here
Classifieds
Cars
Forums
Coupons
News Archives
Contests
Jobs
Search Hotels in Los Altos
CHECK-IN:
CHECK-OUT:
ROOMS:
1
2
3
4
Find A Business
or
Browse Listings
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gsk Plc ADR
(NY:
GSK
)
35.21
-0.78 (-2.17%)
Official Closing Price
Updated: 4:10 PM EST, Dec 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gsk Plc ADR
< Previous
1
2
3
4
5
6
7
8
9
...
35
36
Next >
GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex
Today 13:14 EST
GSK's Blenrep combo demonstrates significant survival benefits and improved efficacy in relapsed multiple myeloma compared to Darzalex combo.
Via
Benzinga
Belantamab Mafodotin shows significant overall survival benefit, reducing the risk of death by 42% in multiple myeloma at or after first relapse
December 09, 2024
From
GSK plc
Via
Business Wire
Oracle, Vertiv And A Health Care Stock On CNBC's 'Final Trades'
December 09, 2024
On CNBC's "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors said Oracle is going to report a strong quarter.
Via
Benzinga
Bird Flu Found In Raw Milk Leads To Recall In California
November 26, 2024
Bird flu has been detected in a batch of raw milk sold in California and a voluntary recall of the milk has been issued at the request of the state's department of public health.
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
GSK Stock Crumbles As Vaccine Sales Plummet And Miss Expectations
October 30, 2024
The company said revenue from RSV vaccine tumbled 72%.
Via
Investor's Business Daily
Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of Workforce
November 26, 2024
Alector's AL002 fails in Phase 2 Alzheimer's trial, halting extension study; focus shifts to other programs as workforce is cut by 17%.
Via
Benzinga
Mutated Bird Flu Case In California Puts Humans At Increased Risk, So Which Companies Are Developing Vaccines?
November 20, 2024
According to the Los Angeles Times, the total bird flue case count in the U.S. stands at 54; 31 cases are attributed to the dairy industry.
Via
Benzinga
GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients
November 19, 2024
GSK's phase 3 GLISTEN trial demonstrated linerixibat's potential to treat relentless itch in PBC patients, meeting its primary endpoint.
Via
Benzinga
European And US Vaccine Stocks Are Under Pressure - Here's WHy
November 15, 2024
Vaccine stocks react to Robert F. Kennedy Jr.'s HHS nomination. FDA and NIH express concerns over his anti-vaccine views amid market shifts.
Via
Benzinga
Exposures
Product Safety
GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why
November 14, 2024
GSK's phase 3 trial shows Blenrep combined with BorDex improves overall survival in relapsed multiple myeloma.
Via
Benzinga
Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
November 13, 2024
After years of limited advancements in chronic obstructive pulmonary disease (COPD) treatment, patients now have new options.
Via
Benzinga
Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs
November 12, 2024
23andMe restructures, cutting 40% of its workforce and ending its therapeutic programs to save $35 million annually while exploring strategic alternatives.
Via
Benzinga
Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction'
November 07, 2024
Donald Trump has said he will give Robert F. Kennedy Jr. a senior role in his incoming administration to advance his "Make America Healthy Again" agenda.
Via
Benzinga
Topics
Government
Exposures
Political
Moderna Posts A Surprise Profit As Sales Wallop Views. But Will RSV Be Its Undoing?
November 07, 2024
The company reported just $10 million in sales of its RSV vaccine, mResvia, widely missing expectations.
Via
Investor's Business Daily
GSK's Q3 Earnings Hit By Lower Than Expected Vaccine Sales, Cautions Lower Revenue For 2024
October 30, 2024
GSK reports Q3 sales of $10.42 billion, missing estimates due to an 18% drop in vaccine revenue, while specialty medicines and HIV drugs show growth.
Via
Benzinga
Stock Market Retreats Before Election Day; Microsoft, Apple, Amazon, Google, Meta In Focus: Weekly Review
November 01, 2024
The major indexes declined, but haven't fallen apart.
Via
Investor's Business Daily
Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population
October 24, 2024
GSK unveils new Arexvy data showing strong protection in adults 18-49 at risk for RSV. The vaccine could broaden coverage for millions at risk of serious disease.
Via
Benzinga
New Data for AREXVY, GSK’s Respiratory Syncytial Virus Vaccine, Show Potential to Help Protect a Broader Group of Adults at Increased Risk for RSV Disease
October 24, 2024
From
GSK plc
Via
Business Wire
FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years
October 23, 2024
Pfizer's RSV vaccine Abrysvo receives FDA approval for adults 18-59 at high risk, with extended use for pregnant individuals to safeguard infants from birth.
Via
Benzinga
Exposures
Product Safety
Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.
October 21, 2024
Korro Bio is lagging Wave Life Sciences. But an analyst says it could ultimately be the leader.
Via
Investor's Business Daily
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
October 21, 2024
Via
Benzinga
Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology
October 17, 2024
Northwestern University has filed a lawsuit against Moderna, alleging the company used its patented lipid nanoparticle technology without permission in the development of its COVID-19 vaccines.
Via
Benzinga
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
GSK Seeks FDA Approval For Oral Antibiotic For Urinary Tract Infections, Probably First In New Class In Over 20 Years
October 16, 2024
GSK's gepotidacin, an oral antibiotic for uUTIs, could be the first in over 20 years. The FDA granted Priority Review with a March 2025 decision expected. Trials showed better efficacy than...
Via
Benzinga
Exposures
Product Safety
Wave Life Sciences Reveals RNA Editing Breakthrough, Reports First-Ever Clinical Proof-Of-Mechanism In Humans
October 16, 2024
Wave Life Sciences' WVE-006 demonstrates first-ever RNA editing in humans for alpha-1 antitrypsin deficiency, showing favorable safety and efficacy in early trial results. GSK holds global license...
Via
Benzinga
GSK Sues Moderna Alleging mRNA Vaccine Patent Infringement
October 15, 2024
GlaxoSmithKline has filed a lawsuit against Moderna, claiming its mRNA vaccines infringe on GSK's patents. GSK seeks royalties for Moderna's alleged unlicensed use of its groundbreaking vaccine...
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
GSK Says Depemokimab For Chronic Rhinosinusitis Reduces Nasal Polyp Size, Nasal Obstruction Versus Placebo At One Year
October 14, 2024
GSK's depemokimab met key endpoints in phase 3 trials for chronic rhinosinusitis with nasal polyps (CRSwNP), showing promise in reducing nasal polyp growth and obstruction. Full results to be presented...
Via
Benzinga
2 Best Artificial Intelligence Stocks to Buy in October
October 13, 2024
These companies could have more growth ahead than investors realize.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
GSK Settles Majority Of Zantac Lawsuits, But Pipeline Doubts Remain
October 11, 2024
GSK settles 93% of Zantac lawsuits with a $2.2 billion payout, easing investor concerns. However, doubts over its future growth persist as challenges with its drug pipeline remain.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
October 11, 2024
Sanofi is negotiating a potential sale of a 50% stake in its consumer health unit, Opella, to Clayton Dubilier & Rice. The deal, valued at $16.4 billion, could help Sanofi sharpen its focus on...
Via
Benzinga
GSK, Pfizer Face Declining Respiratory Syncytial Virus Vaccine Sales Due To Narrow Age Recommendations
October 10, 2024
RSV vaccine sales from GSK and Pfizer have dropped significantly following revised CDC guidelines, narrowing the eligible age group and reducing demand by two-thirds compared to last year.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
35
36
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
About Us
|
Contact Us
|
Privacy Policy
|
User Agreement
|
Advertise With Us
|
Site Map
Home
|
News
|
Travel
|
Restaurants
|
Nightlife
|
Things To Do
|
Shopping
|
Events
|
Directory
|
Real Estate
|
Blog
|
More
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.